Pharmaceutical

Image

Global Desmopressin Market – Industry Trends and Forecast to 2030

  • Pharmaceutical
  • Upcoming Report
  • Dec 2022
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Desmopressin Market – Industry Trends and Forecast to 2030

Market Size in USD Billion

CAGR - % Diagram

Diagram Forecast Period 2022–2030
Diagram Market Size (Base Year) USD 1055.63 Million
Diagram Market Size (Forecast Year) USD 1657.28 Million
Diagram CAGR %

Global Desmopressin Market, By Form (Injectable Solution, Nasal Spray, Tablet), Applications (Paediatric Use and Geriatric Use), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) – Industry Trends and Forecast to 2030.

Desmopressin Market Analysis and Size

Desmopressin is used to treat a wide variety of medical conditions, which includes nocturnal polyuria, diabetes insipidus, hemophilia A, Willebrand disease, uremic bleeding. The increasing incidence of diabetes insipidus among people and the surge in bedwetting episodes in children have created a successful market for desmopressin acetate globally. Manufacturers in the desmopressin acetate are projected to improve their regional product footprint along with numerous promotional activities such as awareness programs about the measures to prevent nighttime bedwetting, treatment of diabetes insipidus.

Data Bridge Market Research analyses a growth rate in the desmopressin market in the forecast period 2023-2030. The expected CAGR of desmopressin market is tend to be around 5.8% in the mentioned forecast period. The market was valued at USD 1055.63 million in 2022, and it would grow upto USD 1657.28 million by 2030. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Desmopressin Market Scope and Segmentation

Report Metric

Details

Forecast Period

2023 to 2030

Base Year

2022

Historic Years

2021 (Customizable to 2015 - 2020)

Quantitative Units

Revenue in USD Million, Volumes in Units, Pricing in USD

Segments Covered

Form (Injectable Solution, Nasal Spray, Tablet), Applications (Paediatric Use and Geriatric Use), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

Market Players Covered

Pfizer Inc (U.S.), Teva Pharmaceutical Industries Ltd (Israel), NorthStar Rx LLC (U.S.), Sun Pharmaceutical Industries Ltd. (India), avenit software shanghai ltd (China), Ferring B.V. (Switzerland), Amring Pharmaceuticals Inc. (U.S.), Apotex Inc (Canada), Glenmark Pharmaceuticals Ltd (India), Mylan N.V. (U.S.)

Market Opportunities

  • Increasing Investments by Several market Players

Market Definition

Desmopressin is a type of vasopressin and is widely used to replace a low level of vasopressin. The desmopressin medication aids in controlling the rising urge of urination and dehydration. It has also been used to control night-time bedwetting in children. Furthermore, in conditions such as diabetes insipidus, wherein the body produces an abnormally large amount of urine, desmopressin medicines have been used widely.

Desmopressin Market Dynamics

Drivers

  • Growing Prevalence of Diabetes

The number of people suffering from diabetes rise from 108 million in 1980 to 422 million in 2014. Prevalence has increased rapidly in low and middle-income countries compared to high-income countries. Between 2000 and 2019, there was a 3% increase in diabetes mortality rates by age. In 2019, diabetes and kidney disease due to diabetes caused an estimated 2 million deaths. Numerous studies have shown that zinc improves glucose levels in people suffering from diabetes. This leads to the market growth.

  • Increased Awareness About the Diseased Conditions

The developing research associated with the market increases the expansion rate during the forecast period. The more adoption of clinical drugs for this diseased condition will bring much favourable outcomes. Furthermore, the treatment involves both counseling sessions and drugs. Therefore, the market tends to grow at a fast pace considering both the options.

Opportunities

  • Increasing Investments by Several market Players

There have been rising investments by multiple market players that are helping boost the market's growth. For instance, in September 2017, Amring Pharmaceuticals announced its plans to invest in desmopressin acetate to meet its commitment of providing high-quality generic medicines and excellent customer service at a reasonable price.

Restraints/Challenges

  • Side-Effects of Antipsychotic Drugs

Desmopressin can show major complications. Heavy dosage of this drug can cause flushing, nausea, transient headache, and mild abdominal cramps. This hampers the market growth.

This desmopressin market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the desmopressin market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Desmopressin Market Scope

The desmopressin market is segmented on the basis of form, applications, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Form

  • Injectable Solution
  • Nasal Spray
  • Tablet

Applications

  • Paediatric Use
  • Geriatric Use

End User

  • Hospitals
  • Homecare
  • Specialty Clinics
  • Others

Distribution Channel

  • Hospital Pharmacy
  • Online Pharmacy
  • Retail Pharmacy

Desmopressin Market Regional Analysis/Insights

The desmopressin market is analyzed and market size insights and trends are provided by form, applications, distribution channel and end-user as referenced above.

The major countries covered in the desmopressin market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

Asia-Pacific will expect the highest growth for the desmopressin market throughout the forecasted period due to increased new research and developments on the desmopressin market.

North America dominates the market due to the presence of key manufacturers of the product is high and, increasing research and development activities.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and Global Desmopressin Market Share Analysis

The desmopressin market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to desmopressin market.

Key players operating in the desmopressin market include:

  • Pfizer Inc (U.S.)
  • Teva Pharmaceutical Industries Ltd (Israel)
  • NorthStar Rx LLC (U.S.)
  • Sun Pharmaceutical Industries Ltd. (India)
  • avenit AG (China)
  • Ferring B.V. (Switzerland)
  • Amring Pharmaceuticals Inc. (U.S.)
  • Apotex Inc (Canada)
  • Glenmark Pharmaceuticals Ltd (India)
  • Mylan N.V. (U.S.)


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

FREQUENTLY ASK QUESTIONS

The Desmopressin Market will be worth USD 1657.28 million by 2030 in the forecast period.
The Desmopressin Market growth rate is 5.8% during the forecast period.
Growing Prevalence of Diabetes and increased Awareness About the Diseased Conditions are the growth drivers of the Desmopressin Market.
The form, applications, distribution channel and end-user are the factors on which the Desmopressin Market research is based.
Major companies in the Desmopressin Market are Pfizer Inc (U.S.), Teva Pharmaceutical Industries Ltd (Israel), NorthStar Rx LLC (U.S.), Sun Pharmaceutical Industries Ltd. (India), avenit software shanghai ltd (China), Ferring B.V. (Switzerland), Amring Pharmaceuticals Inc. (U.S.), Apotex Inc (Canada), Glenmark Pharmaceuticals Ltd (India), Mylan N.V. (U.S.).
Free Sample Report

CHOOSE LICENCE TYPE

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials